Penumbra, Inc. Prepares for Major Healthcare Presentation
Penumbra, Inc. (NYSE: PEN) is excited to announce that its management team is set to present at a prestigious healthcare event organized by Piper Sandler. The 37th Annual Healthcare Conference, taking place on December 3, promises to be a platform for showcasing Penumbra's groundbreaking medical technologies and advancements.
Event Details
The event presents an opportunity for industry leaders to engage and exchange insights on the latest developments in healthcare technology. The presentation will kick off at 8:00 AM ET, allowing for engaging discussions and sharing of knowledge.
What to Expect
At this annual conference, Penumbra will highlight its innovative thrombectomy technologies designed to address challenging medical conditions, such as ischemic stroke and venous thromboembolism. These technologies not only aim to save lives but also improve the overall quality of care provided to patients worldwide.
About Penumbra, Inc.
As a leader in the thrombectomy sector, Penumbra, Inc. focuses on developing advanced technologies that tackle medical challenges head-on. Their broad portfolio includes computer-assisted vacuum thrombectomy (CAVT), created to efficiently and safely remove blood clots from various parts of the body. With operations in over 100 countries, Penumbra strives to enhance patient outcomes and elevate living standards through innovative healthcare solutions.
Webcast Availability
For those interested in following the discussions and advancements presented at the conference, a webcast will be accessible through the company's website. This will provide an opportunity for a wider audience to engage with Penumbra's commitment to healthcare innovation. The webcast will remain available for at least two weeks after the event, ensuring everyone has a chance to catch up on the insights shared.
Investor Relations
For more detailed information regarding their upcoming initiatives, future prospects, and investor engagement, stakeholders are encouraged to check out the Investor Relations section on Penumbra’s website, aiming to keep all parties informed and invested in the company's journey.
Frequently Asked Questions
What is Penumbra, Inc. focused on?
Penumbra, Inc. specializes in innovating thrombectomy technologies to improve treatment processes for serious medical conditions, like strokes.
When will Penumbra present at the Piper Sandler Healthcare Conference?
Penumbra's management team is scheduled to present on December 3 during the event.
Where can I find more information post-event?
A webcast of the presentation will be available on Penumbra's website for at least two weeks following the event.
How does Penumbra improve patient outcomes?
By offering cutting-edge technologies that streamline medical processes, Penumbra helps healthcare providers to deliver better care and improve patient quality of life.
Is Penumbra, Inc. publicly traded?
Yes, Penumbra, Inc. trades on the NYSE under the ticker symbol PEN.
